Therefore, delineating the precise physiological function of mGluR4 in astrocytes and how this function is disrupted by Aβ can be very useful in designing novel therapies for AD and possibly other neurological conditions characterized by excessive glutamate release (Fig. 1). The gene discussed is GRM4; the disease is Alzheimer disease.